PBTQ Gains, Lifted by Celgene, Genzyme Friday, October 1, 8:43 AM ET, by Market News Video Staff The PowerShares Global Biotech Portfolio (PBTQ) has a market value of only $3.7 million, but ...
Gilead Sciences 23.68% of Biotech HOLDRS ETF Thursday, October 7, 8:24 AM ET, by Market News Video Staff Gilead Sciences (GILD) makes up 23.68% of the Biotech HOLDRS (BBH) ETF. The Biotech HOLDRS ...
IBB Sees Heavy Shorting, Largest Holding Amgen Monday, October 25, 10:08 AM ET, by Market News Video Staff There are 7,884,900 shares short of the iShares Nasdaq Biotechnology Index Fund (IBB) according to ...
AMGN, BIIB Initiated at Sell Thursday, November 4, 12:51 PM ET, by Market News Video Staff Coverage of both Amgen (AMGN) and Biogen Idec (BIIB) was initiated at Goldman Sachs (GS) ...
CELG Crosses Below Key Moving Average Level Monday, April 18, 2:17 PM ET, by Market News Video Staff In trading on Monday, shares of Celgene Corp. (CELG) crossed below their 200 day moving ...
In trading on Wednesday, shares of Celgene Corp. (NASDAQ:CELG) crossed above their 200 day moving average of $57.42, changing hands as high as $57.56 per share. Celgene Corp. shares are currently trading off about 0.3% on the day. The chart below shows the one year performance of CELG shares, versus its 200 day moving average:
Looking at the chart above, CELG's low point in its 52 week range is $48.92 per share, with $63.46 as the 52 week high point — that compares with a last trade of $57.21.
CELG operates in the Biotechnology sector, among companies like Protalix BioTherapeutics Inc (AMEX:PLX) which is down about 0.4% today, and Endocyte Inc (NASDAQ:ECYT) trading up by about 0.6%. Below is a three month price history chart comparing the stock performance of CELG, versus PLX and ECYT.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AboveAccordingBelowBioTherapeuticsBiotechnologyCELGCelgeneChannelCorpECYTETFsEndocyteInvestmentMovingNASDAQPortfolioWednesdayaboutaboveallowsamongassetaveragechartcompaniescompletelycurrentlydesignedgrowthhandshighhistorymovingoperatesotherperformancepointportfoliopricerangesharesharesstockstermstradingversusweekwhatwhichwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Now Playing:
Learn About The 200 DMA
Start slideshow:
Thursday 5/24 Insider Buying Report: ANF, POL
Footwear Earnings: FL, BW
Daily Dividend Report: LO, HD, TWC. APD, HPQ
Daily Market Overview
Analyst Moves: CHS, HSY
Daily Dividend Report: MMC, MO, POT, YUM, HAL, WMB
